KMT2D and cancer: In LUSC, a predominance of tumor regions with driver mutations in ATR and KMT2D was observed along with predicted hypermethylation of PITX2 or VIRP2, MethSig cancer genes with an MR/MN greater than 1 (Supplementary Fig. 7).